Furthermore, IL-6 can promote myocardial fibrosis by activating the TGF-β1 pathway or interfering with myocardial metabolism, worsening the overall condition of HF patients through multiple mechanisms (35, 36). Here, TGFB1 is linked to Myocardial fibrosis.